Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Lymphoma

Free Subscription 22.07.2024 1 Am J Surg Pathol 4 Blood 1 Br J Dermatol 3 Haematologica 4 J Am Acad Dermatol 1 J Clin Oncol 2 Leuk Lymphoma 2 Leukemia 1 PLoS Comput Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg Pathol

1. ZENG Y, Wei R, Bao L, Xue T, et al
   Characteristics and Clinical Value of MYC , BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL.
   Am J Surg Pathol. 2024;48:919-929.
   PubMed         Abstract available
   
   

   
   Blood

2. TE VRUGT M, Wessolowski JS, Randau G, Alfert A, et al
   Pediatric T-cell lymphoblastic lymphoma but not leukemia harbor TRB::NOTCH1 fusions with unfavorable outcome.
   Blood. 2024 Jul 18:blood.2024025307. doi: 10.1182/blood.2024025307.
   PubMed         Abstract available
   
   
3. RYAN CE, Cohen JB
   Is rituximab retro in mantle cell lymphoma?
   Blood. 2024;144:241-243.
   PubMed        
   
   
4. NABEEL H, Bhagat G
   Double-hit, double-expressor follicular lymphoma with plasmacytic differentiation.
   Blood. 2024;144:339.
   PubMed        
   
   
5. 
   Armand P, Zinzani PL, Lee HJ, et al. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma. Blood. 2023;142(10):878-886.
   Blood. 2024;144:341.
   PubMed        
   
   

   
   Br J Dermatol

6. BATTISTELLA M
   Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
   Br J Dermatol. 2024;191:158-159.
   PubMed        
   
   

   
   Haematologica

7. MELODY M, Gordon LI
   Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma.
   Haematologica. 2024 Jul 18. doi: 10.3324/haematol.2024.285255.
   PubMed         Abstract available
   
   
8. GARGANO G, Vegliante MC, Esposito F, Pappagallo SA, et al
   A targeted gene signature stratifying mediastinal gray zone lymphoma into classical HL-like or PMBL-like subtypes.
   Haematologica. 2024 Jul 18. doi: 10.3324/haematol.2024.285266.
   PubMed         Abstract available
   
   
9. OTHMAN T, Frankel P, Allen P, Popplewell LL, et al
   Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphoma.
   Haematologica. 2024 Jul 18. doi: 10.3324/haematol.2024.285185.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

10. HASAN I, Zinn Z
    Response to Shih et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 10:S0190-9622(24)01046.
    PubMed        
    
    
11. SHIH PC, Wei JCC
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 11:S0190-9622(24)01041.
    PubMed        
    
    
12. BRUMBAUGH BJ, Thompson BB, Holt A, Ebriani J, et al
    Delays in Diagnosis in Cutaneous T Cell Lymphoma: A Retrospective Study on Clinical Course and Time to Death.
    J Am Acad Dermatol. 2024 Jul 11:S0190-9622(24)01054.
    PubMed        
    
    
13. FRIEDMAN A
    JAAD Game Changers: "Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium".
    J Am Acad Dermatol. 2024 Jul 17:S0190-9622(24)02503.
    PubMed        
    
    

    
    J Clin Oncol

14. CAMPO E, Dierickx D, Dirnhofer S, Dunleavy K, et al
    Lymphoma Classifications, How to Develop a Future Unified Taxonomy.
    J Clin Oncol. 2024 Jul 17:JCO2400070. doi: 10.1200/JCO.24.00070.
    PubMed        
    
    

    
    Leuk Lymphoma

15. ADEUYAN O, Ouseph MM, Bao L, Kluk MJ, et al
    A case of testicular diffuse large B-cell lymphoma with late relapse in the skin: the critical role of comparative phenotypic, clonality, and cytogenetic testing.
    Leuk Lymphoma. 2024 Jul 17:1-5. doi: 10.1080/10428194.2024.2374455.
    PubMed        
    
    
16. CROMBIE JL, Jun M, Wang T, Mutebi A, et al
    Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2024 Jul 16:1-11. doi: 10.1080/10428194.2024.2371472.
    PubMed         Abstract available
    
    

    
    Leukemia

17. MONDELLO P
    Silencing GNAS enhances HDAC3i efficacy in CREBBP wild type B cell lymphoma.
    Leukemia. 2024 Jul 19. doi: 10.1038/s41375-024-02355.
    PubMed         Abstract available
    
    
18. JINDAL U, Mamgain M, Nath UK, Sharma I, et al
    Targeting CERS6-AS1/FGFR1 axis as synthetic vulnerability to constrain stromal cells supported proliferation in Mantle cell lymphoma.
    Leukemia. 2024 Jul 13. doi: 10.1038/s41375-024-02344.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

19. SCHMIDT-BARBO P, Kalweit G, Naouar M, Paschold L, et al
    Detection of disease-specific signatures in B cell repertoires of lymphomas using machine learning.
    PLoS Comput Biol. 2024;20:e1011570.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.